Buscar en
Endocrinología, Diabetes y Nutrición (English ed.)
Toda la web
Inicio Endocrinología, Diabetes y Nutrición (English ed.)
Journal Information
Issue
Vol. 69. Issue 5.
Pages 313-388 (May 2022)
Editorial
The role of immunotherapy in endocrine cancer treatment
Juan Cristóbal Sánchez, Pedro Iglesias
Endocrinol Diabetes Nutr. 2022;69:313-5
Original articles
Evaluation of the usefulness of and satisfaction with the flash glucose monitoring system (FreeStyle Libre®) guide for use in patients with type 1 diabetes⋆
Manuel Mateu-Salat, Jesús Moreno-Fernández, Natalia Mangas, Idoia Genua, María José Martínez, Alicia López, Cintia González, Ana Chico
Endocrinol Diabetes Nutr. 2022;69:316-21
Relationship between soluble protein ST2 (sST2) levels and microvascular complications in a cohort of patients with type 1 diabetes
Luis Forga, Natalia López-Andrés, Ibai Tamayo, Amaya Fernández-Celis, Marta García-Mouriz, María José Goñi
Endocrinol Diabetes Nutr. 2022;69:322-30
A real-life study of the medium to long-term effectiveness of a hypercaloric, hyperproteic enteral nutrition formula specifically for patients with diabetes on biochemical parameters of metabolic control and nutritional status
María D. Ballesteros Pomar, Beatriz Lardiés Sánchez, María Argente Pla, Araceli Ramos Carrasco, Lorena Suárez Gutiérrez, Alfredo Yoldi Arrieta, Patricia Sorribes Carreras, Sonsoles Gutiérrez Medina, Juan Bautista Molina Soria, María Berrio Miranda, M. Socorro Leyva Martínez, Oscar Torregrosa Suau, María Teresa Oliván Usieto, Francisco Villazón González, Jimena Abilés Osinaga, Esteban Martín Echevarría, Katherine García-Malpartida
Endocrinol Diabetes Nutr. 2022;69:331-7
Evaluation of a perioperative steroid coverage after pituitary surgery
Ana Irigaray Echarri, M. Dolores Ollero García-Agulló, Ana Iriarte Beroiz, Marta García Mouriz, Idoya Zazpe Cenoz, Sara Laguna Muro, Luis Muñoz de Dios, Emma Anda Apiñániz
Endocrinol Diabetes Nutr. 2022;69:338-44
Impact of flash glucose monitoring on quality of life and glycaemic control parameters in adults with type 1 diabetes mellitus⋆
Rebeca Jiménez-Sahagún, Emilia Gómez Hoyos, Gonzalo Díaz Soto, María de la O Nieto de la Marca, Marta Sánchez Ibáñez, Sofía del Amo Simón, Beatriz Torres Torres, Juan José López Gómez, Esther Delgado García, Ana Ortolá Buigues, Daniel de Luis Román
Endocrinol Diabetes Nutr. 2022;69:345-53
Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes
Fatma Nur Korkmaz, Asena Gökçay Canpolat, Sevim Güllü
Endocrinol Diabetes Nutr. 2022;69:354-61
Special article
Effectiveness of training in disease management for patients with type 2 diabetes mellitus: A systematic review
Ezgi Bağriaçik, Nurhan Bayraktar
Endocrinol Diabetes Nutr. 2022;69:362-78
Scientific letters
A not so insignificant appointment at the dentist
Laurence Salle, Julie Usseglio, Henri Salle
Endocrinol Diabetes Nutr. 2022;69:379-81
Parasitic thyroid nodules: The differential diagnosis
Jesús Moreno-Fernández, Violeta Herrera Montoro, Rita Virlaboa Cebrian, Francisco José Martín Davila
Endocrinol Diabetes Nutr. 2022;69:381-2
Unusual clinical presentation and new mutation in a case of triple A syndrome
María Eugenia López Valverde, María Isabel Rebollo Pérez, Eva María Martínez Fernández, Eva Murillo Espejo, Pilar Carrasco Salas
Endocrinol Diabetes Nutr. 2022;69:382-4
5-Alpha-reductase type 2 deficiency. A new case in the Spanish population
Mikel González Fenández, Isabel Esteva de Antonio, Idoia Martínez de la Piscina Martín, Jorge Soler Martínez, María Cruz Almaraz Almaraz
Endocrinol Diabetes Nutr. 2022;69:384-6
Letter to the editor
Comment on the article Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes
Sandro Gentile, Giuseppina Guarino, Ersilia Satta, Felice Strollo
Endocrinol Diabetes Nutr. 2022;69:387-8
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos